Pfizer Withdraws Oxbryta, But Overall Market Impact May Be Limited

EU Regulators Recommend Suspending Approval

• Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Blood and Clotting

More from Therapy Areas